In non-small cell lung cancer, POLQ upregulates DNA replication initiation proteins such as CDC6 and PLK1, enhancing tumor cell tolerance to replication stress, promoting cell proliferation, and resulting in poor prognosis (Allera-Moreau et al. 2012). Here, PLK1 is linked to neoplasm.